G Model
CRAS2C-3718; No. of Pages 8
P.K. Kalita, P. Phukan / C. R. Chimie xxx (2013) xxx–xxx
7
1-(4-Fluorophenyl)but-3-en-1-ol,5e (3k). IR (
3359, 3078, 2944, 2858,1845, 1640, 1487, 1370; 1H-NMR
(300 MHz, CDCl3): 7.40–7.17 (m, 2H), 7.13–6.92 (m,
2H), 5.89–5.60 (m, 1H), 5.26–4.99 (m, 2H), 4.74–4.52 (m,
1H), 3.22 (s, 1H), 2.58–2.31 (m, 2H); 13C-NMR (75 MHz,
y
/cmÀ1):
1.90 (s, 1H); 13C-NMR (75 MHz, CDCl3): 136.6, 134.0, 131.5,
130.4, 128.6, 127.7, 126.5, 118.6, 71.7, 42.0.
d
1-phenyl-1-methylbut-3-en-1-ol,5a (5a). IR ( /cmÀ1):
y
3440, 3069, 2977, 1641, 1444, 1371, 1068; 1H-NMR
(300 MHz, CDCl3): 7.47–7.23 (m, 5H), 5.72–5.62 (m,
d
CDCl3):
43.5.
d
160.2, 139.5, 134.0, 127.3, 118.0, 114.8, 72.6,
1H), 5.18–5.12 (m, 2H), 2.71 (dd, J1 = 13.6 Hz, J2 = 6.42 Hz,
1H), 2.55–2.48 (m, 1H), 1.57 (s, 3H, CH3); 13C-NMR
1-(2,4-Dichlorophenyl)but-3-en-1-ol,5e, 8b (3l). IR (
y
/
(75 MHz, CDCl3):
d 147.5, 133.5, 128.0, 126.6, 125.0,
cmÀ1): 3278, 3080, 2938, 1639,1470,1071, 1045; 1H-NMR
(300 MHz, CDCl3): 7.42 (d, J = 8.69 Hz, 1H), 7.37–7.17 (m,
2H), 5.93–5.68 (m, 1H), 5.32–4.94 (m, 3H), 2.91 (s, 1H),
2.66–2.44 (m, 1H), 2.41–2.19 (m, 1H); 13C-NMR (75 MHz,
119.3, 73.5, 48.3, 29.7.
d
1-(o-Hydroxyphenyl)-1-methylbut-3-en-ol,5a (5b). IR
(
y
/cmÀ1): 3439, 3072, 2975, 1645, 1441, 1377, 1071; 1H-
NMR (300 MHz, CDCl3):
d 9.26 (s, 1H), 7.19–6.81 (m, 4H),
CDCl3):
118.7, 68.9, 41.7.
d
139.6, 133.6, 133.2, 131.9, 128.8, 127.8, 127.1,
5.83–5.75 (m, 1H), 5.22–5.17 (m, 2H), 2.84–2.77 (m, 1H,),
2.59–2.52 (m, 1H,), 1.63 (s, 3H, CH3); 13C-NMR (75 MHz,
CDCl3): d 155.7, 132.9, 129.3, 128.8, 125.9, 120.3, 119.5,
1-(4-Ethylphenyl)but-3-en-1-ol,5f (3m). IR (
y
/cmÀ1):
3544, 3389, 3067, 2931, 1638, 1519, 1432, 1161, 1055; 1H-
117.5, 76.6, 46.5, 28.3.
5c
NMR (300 MHz, CDCl3):
d
7.30 (d, J = 7.93 Hz, 1H), 7.23 (d,
1-(p-Methylphenyl)-1-methylbut-3-en-1-ol,5a,
J = 7.93 Hz, 1H) 5.95–5.73 (m, 1H), 5.28–5.09 (m, 2H), 4.68
(t, J = 6.42 Hz, 1H), 3.03 (s, 1H), 2.72 (q, J = 7.5 Hz, 2H), 2.53
(t, J = 6.8 Hz, 2H), 1.42- 1.27 (m, 3H); 13C-NMR (75 MHz,
(5c). IR (
1062; 1H-NMR (300 MHz, CDCl3):
y
/cmÀ1): 3441, 3064, 2977, 1641, 1444, 1373,
d
7.37 (d, J = 7.93 Hz,
2H), 7.19 (d, J = 7.55 Hz, 2H), 5.71–5.62 (m, 1H), 5.19–5.13
(m, 2H), 2.71 (dd, J1 = 13.6 Hz, J2 = 6.42 Hz, 1H), 2.52 (dd,
J1 = 13.6 Hz, J2 = 8.31 Hz, 1H,), 2.38 (s, 3H, CH3), 1.56 (s, 3H,
CH3); 13C-NMR (75 MHz, CDCl3):
d 144.7, 136.2, 133.9,
CDCl3):
43.4, 28.3, 15.4.
d 143.1, 141.0, 134.5, 127.6, 125.7, 117.5, 73.1,
1-(3,4-Dimethoxyphenyl)but-3-en-1-ol,7b (3n). IR (
y
/
cmÀ1): 3545, 3381, 3069, 2937, 1620, 1509, 1433, 1182,
128.9, 124.8, 119.4, 73.6, 48.5, 29.9, 21.0.
1055; 1H-NMR (300 MHz, CDCl3):
d
6.92–6.69 (m, 3H),
1-(p-Fluorophenyl)-1-methylbut-3-en-ol,5a (5d). IR
5.84–5.63 (m, 1H), 5.17–4.97 (m, 2H), 4.67–4.51 (m, 1 H),
3.82 (s, 3H), 3.80 (s, 3H), 2.57 (s, 1H), 2.48–2.39 (m, 2H);
13C-NMR (75 MHz, CDCl3):
(y
/cmÀ1): 3445, 3062, 2971, 1639, 1440, 1372, 1062;
1H-NMR (300 MHz, CDCl3):
d 7.43–7.38 (m, 2H, ArH), 7.12–
d
148.6, 148.0, 136.4, 134.4,
6.99 (m, 2H, ArH), 5.66–5.57 (m, 1H), 5.16–5.11 (m, 2H),
117.8, 110.6, 108.7, 73.0, 55.6, 43.5.
2.66 (dd, J1 = 13.6 Hz, J2 = 6.42 Hz, 1H), 2.52–2.45 (m, 1H),
8b
1-(2-Bromophenyl)but-3-en-1-ol,5e,
(3o). IR (
y
/
1.54 (s, 3H, CH3); 13C-NMR (75 MHz, CDCl3):
d
163.2, 159.9,
143.3, 133.3, 126.4, 119.7, 114.6, 73.3, 48.4, 29.9.
1-Cyclohexylbut-3-en-1-ol,10, 5a, 5c (5e). IR (
3362, 3067, 2926, 2856,1828, 1640, 1452, 1376; 1H-NMR
(300 MHz, CDCl3): 5.95–5.81 (m, 1H), 5.16–5.13 (m, 2H),
2.23–2.20 (m,2H), 1.70–1.38 (m, 10H); 13C-NMR (75 MHz,
CDCl3): 138.8, 133.7, 122.7, 118.7, 70.9, 46.6, 37.3, 29.7,
25.5, 22.1.
1-Cycloheptylbut-3-en-1-ol,5a (5f). IR (
3068, 2936, 1621, 1505, 1185, 1056; 1H-NMR (300 MHz,
cmÀ1): 3297, 3070, 2933, 1640, 1498, 1465, 1433, 1065;
1H-NMR (300 MHz, CDCl3):
d
7.62–7.44 (m, 2H), 7.31 (t,
y
/cmÀ1):
J = 7.2 Hz, 1H), 7.22–7.04 (m, 1H), 6.00–5.70 (m, 1H), 5.31–
4.94 (m, 3H), 2.99 (s, 1H), 2.67–2.51(m, 1H), 2.43–2.27 (m,
d
1H); 13C-NMR (75 MHz, CDCl3):
d 142.6, 134.1, 132.4,
128.6, 127.4, 127.2, 121.6, 118.2, 71.7, 41.8.
d
1-(Naphthalen-2-yl)but-3-en-1-ol,26f,
(3p). IR (y/
12
cmÀ1): 3547, 3382, 3069, 2932, 1639, 1511, 1431, 1161,
y
/cmÀ1): 3550,
1056; 1H-NMR (300 MHz, CDCl3):
d 8.21–7.71 (m, 4H),
7.40–6.72 (m, 3H), 6.03–5.71 (m, 1H), 5.34–5.06 (m, 2H),
CDCl3) d 5.94–5.80 (m, 1H), 5.13–5.05 (m, 2H), 2.21–2.19
5.00–4.76 (m, 1H), 3.13 (s, 1H), 2.63 (t, J = 6.42 Hz, 2H); 13C-
(m, 2H), 1.65–1.54 (m, 12H); 13C-NMR (75 MHz, CDCl3)
134.0, 118.5, 74.8, 47.7, 41.4, 30.3, 22.2.
d
NMR (75 MHz, CDCl3):
127.5, 125.9, 125.6, 124.4, 117.9, 73.2, 43.3.
Undec-1-en-4-ol,11 (3q). IR ( /cmÀ1): 3363, 3074,
2927, 2857, 1828, 1641, 1458, 1377; 1H-NMR (300 MHz,
CDCl3): 5.96–5.66 (m, 1H), 5.24–5.03 (m, 2H), 3.96–3.73
(m, 1H), 3.17(s, 1H, OH), 2.41–2.14 (m, 2H), 1.55–1.09 (m,
15 H); 13C-NMR (75 MHz, CDCl3):
134.9, 117.8, 45.9, 31.6,
31.5, 30.9, 29.8, 29.4, 29.1, 26.1, 22.5, 21.2, 13.9.
1-Phenylhex-5-en-3-ol,10 (3r). IR /cmÀ1): 3367,
3064, 2931, 1632, 1517, 1432, 1162, 1051; 1H-NMR
(300 MHz, CDCl3): 7.51–7.12 (m, 5H), 6.00–5.76 (m,
d 141.1, 134.2, 132.9, 127.9, 127.8,
1-Cyclopentylbut-3-en-1-ol,5a (5g). IR ( /cmÀ1): 3360,
y
y
3072, 2919, 2845, 1826, 1640, 1457, 1376; 1H-NMR
(300 MHz, CDCl3): 5.94–5.85 (m, 1H), 5.16–5.12 (m,
2H), 2.35–2.32 (m,2H), 1.80–1.61 (m, 8H); 13C-NMR
(75 MHz, CDCl3): 134.6, 118.6, 81.3, 45.8, 38.4, 23.8.
1-(4-Methylcyclohexyl)but-3-en-1-ol,16, 5e (5h). IR (
cmÀ1): 3381, 3065, 2942, 1621, 1510, 1432, 1181, 1056;
1H-NMR (300 MHz, CDCl3):
5.14–5.07 (m, 2H), 2.37–2.34
(m, 2H), 1.38–1.25 (m, 12H); 13C-NMR (75 MHz, CDCl3):
d
d
d
d
y/
(
y
d
d
d
133.7, 118.6, 70.2, 48.4, 40.8, 34.7, 32.2, 31.1, 30.2, 22.3,
20.1.
1H), 5.33–5.08 (m, 2H), 3.87–3.64 (m, 1H), 2.99–2.61 (m,
2H), 2.55–2.16 (m, 3H), 2.01–1.71 (m, 2H); 13C-NMR
4-Methyl-hept-1-en-4-ol,5a, 16 (5i). IR ( /cmÀ1): 3542,
y
(75 MHz, CDCl3):
d
141.9, 134.5, 128.3, 128.2, 125.6, 117.9,
3067, 2932, 1508, 1183, 1056; 1H-NMR (300 MHz, CDCl3):
69.8, 41.8, 38.2, 31.8.
d 5.87–5.78 (m, 1H), 5.10–5.04 (m, 2H), 2.18 (d, J = 7.18 Hz,
1-Phenyl-hexa-1,5-dien-3-ol,26f (3s). IR
(
y
/cmÀ1):
2H), 1.41–0.91 (m, 10H); 13C-NMR (75 MHz, CDCl3):
134.2, 118.4, 72.2, 46.3, 44.1, 26.6, 17.2, 17.1.
d
3542, 3381, 3072, 2930, 1638, 1520, 1431, 1156; 1H-
NMR (300 MHz, CDCl3)
J = 15.86 Hz, 1H), 6.25 (dd, J1 = 6.42 Hz, J2 = 15.86 Hz, 1H),
6.00–5.75 (m, 1H), 5.33–5.06 (m, 2H), 2.59–2.28 (m, 2H),
d
: 7.62–7.14 (m, 5H), 6.62 (d,
4-Methyl-oct-1-en-4-ol,5d (5j). IR /cmÀ1): 3542,
(y
3072, 2940, 1620, 1510, 1431; 1H-NMR (300 MHz, CDCl3):
5.84–5.73 (m, 1H), 5.03–4.97 (m, 2H), 2.33 (t, J = 7.18 Hz,
d
Please cite this article in press as: Kalita PK, Phukan P. SnCl2Á2H2O-mediated Barbier-type allylation: A comparative